Table 1.
Evaluation of the patients who used antibiotic by wards
| Total (N=80) | Intensive care ward (n=16) | Hematology ward (n=12) | Infectious diseases ward (n=12) | Infant wards (n=20) | Pediatric wards (n=20) | |
|---|---|---|---|---|---|---|
| Inappropriate antibiotic use, n (%) | 27 (33.8) | 0 (0) | 4 (33.3) | 3 (25) | 12 (60) | 8 (40) |
| Obtaining sample for culture before, n (%) | 54 (67.5) | 16 (100) | 10 (83.3) | 7 (58.3) | 11 (55) | 10 (50) |
| Consultation with division of infectious diseases, n (%) | 18 (22.5) | 5 (31) | 0 (0) | 12 (100) | 2 (10) | 0 (0) |
| Agent-specific treatment, n (%) | 11 (13.8) | 5 (31.3) | 1 (8.3) | 2 (16.7%) | 1 (5) | 2 (10) |
| Prophylactic treatment, n (%) | 8 (10) | 1 (6.3) | 4 (33.3) | 0 (0) | 1 (5) | 2 (10) |
| Empiric treatment, n (%) | 61 (76.3) | 10 (62.5) | 7 (58.3) | 10 (83.3) | 18 (90) | 16 (80) |
| Use of multiple antibiotics, n (%) | 43 (53.8) | 14 (87.5) | 7 (8.3) | 7 (58.3) | 10 (50) | 5 (25) |
| PCT (ng/mL) | 0.33 (0.05–2.13) | 0.9 (0.2–4.5) | 0.08 (0.05–0.48) | 1 (0.05–4.28) | 0.7 (0.2–1.56) | 0.05 (0.05–15.2) |
| CRP (mg/L) | 13.7 (3.3–55) | 12.7 (5.6–65) | 8.7 (3.3–25) | 27 (4.8–6.01) | 3.3 (3.3–18.95) | 11.3 (3.3–54.2) |
| WBC (x103/mm3) | 10.3 (7.59–16) | 10.5 (6.4–15.7) | 8 (3.72–28.17) | 10.95 (8.74–14.18) | 11.19 (8.55–15.3) | 10.07 (7.67–17.07) |
| Neutrophil (%) | 58 (36–74) | 42 (68–75) | 38 (4–73) | 65 (52–76.2) | 4.14 (28–65) | 56 (38–65) |
CRP: C-reactive protein; PCT: procalcitonin; WBC: white blood cell count